Leslie Katz led a team that explored the intersection of tech and culture, plus all manner of awe-inspiring science, from space to AI and archaeology. When she's not smithing words, she's probably ...
SOUTH BEND, Ind. (WSBT) — Life-saving medicine at a life changing price. 2 major asthma inhaler drug makers Astra Zeneca and Boehringer Ingelheim have capped their out-of-pocket price for inhalers at ...
GSK plc GSK announced plans to cap out-of-pocket expenses for its inhaled respiratory portfolio in the United States at $35 per month, following a similar move by rivals AstraZeneca AZN and Boehringer ...
March 18 (Reuters) - Drugmaker AstraZeneca (AZN.L), opens new tab said on Monday it would cap out-of-pocket costs for its inhaled respiratory products at $35 per month in the United States from June, ...
Please provide your email address to receive an email when new articles are posted on . Epinephrine autoinjector costs will be capped at $25 and asthma inhaler costs will be capped at $50. These ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback